Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8602)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 15, 2020 (publication date) through Jul 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu SG, Li HB, Yuan ZN, Liu W, Yang Q, Cheng Y, Wang WJ, Wang GY, Li H. Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report. World J Gastrointest Oncol 2020; 12(10): 1209-1215 [PMID: 33133387 DOI: 10.4251/wjgo.v12.i10.1209] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/1209.htm |
| Number | Citing Articles |
| 1 |
Yuno Goto, Kazuto Tajiri, Shinichi Tanaka, Aiko Murayama, Nozomu Muraishi, Yuka Hayashi, Ichiro Yasuda. A ruptured sarcomatoid hepatocellular carcinoma treated with combined immunotherapy. Clinical Journal of Gastroenterology 2023; 16(2): 244 doi: 10.1007/s12328-023-01758-1
|
| 2 |
Ryo Morisue, Motohiro Kojima, Toshihiro Suzuki, Reiko Watanabe, Naoya Sakamoto, Shingo Sakashita, Kenji Harada, Tokiko Nakai, Genichiro Ishii, Tetsuya Nakatsura, Naoto Gotohda, Shumpei Ishikawa. Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology‐based cross‐organ study. International Journal of Cancer 2023; 153(12): 1997 doi: 10.1002/ijc.34680
|
| 3 |
Chengyin Hu, Mingwei Zhao, Qiang Wei, Zhuo Chen, Baolei Zhao. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature. Medicine 2024; 103(13): e37641 doi: 10.1097/MD.0000000000037641
|
| 4 |
Hai-Yi Long, Tong-Yi Huang, Xiao-Yan Xie, Jian-Ting Long, Bao-Xian Liu. Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis. World Journal of Clinical Cases 2021; 9(21): 5754-5768 doi: 10.12998/wjcc.v9.i21.5754
|
| 5 |
Abid M Sadiq, Minael G Mjemmas, Adnan M Sadiq, Gilbert Z Nkya. Sarcomatoid hepatocellular carcinoma in a young African female. SAGE Open Medical Case Reports 2021; 9 doi: 10.1177/2050313X211052452
|
| 6 |
Roma Raj, Chase J. Wehrle, Nihal Aykun, Henry Stitzel, Wen Wee Ma, Smitha Krishnamurthi, Bassam Estfan, Suneel Kamath, David C. H. Kwon, Federico Aucejo. Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy. Cancers 2023; 15(21): 5220 doi: 10.3390/cancers15215220
|
| 7 |
Chia-Yu Chen, Li-Yuan Bai. Long-term Remission by Nivolumab Monotherapy for Sorafenib-Refractory Hepatocellular Carcinoma. Journal of Cancer Research and Practice 2022; 9(1): 41 doi: 10.4103/JCRP.JCRP_33_21
|
| 8 |
Lintao Chen, Shijian Ruan, Pan Wang, Yongna Cheng, Yubizhuo Wang, Wuwei Tian, Hongbin Zhang, Xiuming Zhang, Wenjie Liang. Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study. Heliyon 2023; 9(3): e14123 doi: 10.1016/j.heliyon.2023.e14123
|
| 9 |
Matthias Pinter, Bernhard Scheiner, David J Pinato. Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice. The Lancet Gastroenterology & Hepatology 2023; 8(8): 760 doi: 10.1016/S2468-1253(23)00147-4
|
| 10 |
Subathra Radhakrishnan, Catherine Ann Martin, Mukul Vij, Komalavalli Subbiah, Lexmi Priya Raju, Gowripriya Gowrishankar, Vidya Harini Veldore, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma. Immunotherapy 2024; 16(6): 371 doi: 10.2217/imt-2023-0243
|
| 11 |
Bin Liang, Tao Huang, Shao-Lei Kuang, Guang-Yuan Xie, Tian-Qi Liu, Yuan-Yuan Chen. Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1212013
|
| 12 |
Naomi Yoshuantari, Yung-Ming Jeng, Jau-Yu Liau, Chia-Hsiang Lee, Jia-Huei Tsai. Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts. Modern Pathology 2023; 36(1): 100042 doi: 10.1016/j.modpat.2022.100042
|
| 13 |
Kotaro Umemura, Hiroshi Shimoda, Keinosuke Ishido, Norihisa Kimura, Taiichi Wakiya, Takuji Kagiya, Kentaro Sato, Yuto Mitsuhashi, Seiji Watanabe, Hirokazu Narita, Tomohiro Chiba, Kenichi Hakamada, Shozo Yokoyama. Microanatomical organization of hepatic venous lymphatic system in humans. PLOS ONE 2023; 18(5): e0286316 doi: 10.1371/journal.pone.0286316
|
| 14 |
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao, Xuehao Wang. Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864106
|
| 15 |
Naoshi Nishida. Genetic insights into sarcomatoid hepatocellular carcinoma: Critical role of ARID2 in pathogenesis and immune feature: Editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”. Clinical and Molecular Hepatology 2025; 31(2): 635 doi: 10.3350/cmh.2025.0071
|
| 16 |
Bin Jia, Peiyi Xia, Junqiang Dong, Wenhao Feng, Wenjia Wang, Enjie Liu, Guozhong Jiang, Yanru Qin. Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1086908
|
| 17 |
Yunxiang Zhou, Linping Dong, Linyun Dai, Sien Hu, Yongji Sun, Yulian Wu, Tao Pan, Xiawei Li. Pathologic complete response of hepatoid adenocarcinoma of the stomach after chemo-immunotherapy: A rare case report and literature review. Frontiers in Surgery 2023; 10 doi: 10.3389/fsurg.2023.1133335
|
| 18 |
Tian-Run Lv, Hai-Jie Hu, Parbatraj Regmi, Fei Liu, Fu-Yu Li. Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 2022; 148(7): 1685 doi: 10.1007/s00432-022-03949-8
|
| 19 |
|
| 20 |
Ji Eun Han, Hyo Jung Cho, Soon Sun Kim, Jae Youn Cheong. Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report. Journal of Liver Cancer 2021; 21(2): 169 doi: 10.17998/jlc.2021.08.26
|
| 21 |
Wei Ji, Yunlong Xing, Jinshu Ma, Zhuo Zhao, Hongqin Xu, Shuang Zheng, Wei Li, Xu Li. Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review. Journal of Hepatocellular Carcinoma 2021; : 1117 doi: 10.2147/JHC.S325182
|